BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24166616)

  • 1. Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.
    Yamada T; Goto N; Tsurumi H; Takata K; Sato Y; Yoshino T; Moriwaki H; Kito Y; Takeuchi T; Iwata H
    Med Mol Morphol; 2014 Sep; 47(3):169-75. PubMed ID: 24166616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Push to Consider Mantle Cell Lymphoma in Adults with Leukemia/Lymphoma with Blastoid Morphology.
    Arinze N; Omar N; Keruakous A; Kolhe R; Savage N
    Hematol Rep; 2023 Oct; 15(4):592-596. PubMed ID: 37873796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma.
    Chuang WY; Chang H; Shih LY; Lin TC; Yeh CJ; Ueng SH; Kuo MC; Kao HW; Liu H; Chang ST; Lee CL; Huang KP; Wang TH; Wan YL; Yu JS; Hsueh C; Chuang SS
    Virchows Arch; 2024 May; ():. PubMed ID: 38733379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential Diagnostic Pitfall.
    Zanelli M; Lugli A; Palicelli A; Sanguedolce F; Zizzo M; Cresta C; Biancafarina S; Martino G; Crescenzi B; Pancetti S; Broggi G; Caltabiano R; Cimino L; Mecucci C; Ascani S
    Curr Oncol; 2023 Jan; 30(1):824-831. PubMed ID: 36661711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes.
    Pizzi M; Bongiovanni L; Lorenzi L; Righi S; Scarmozzino F; Balzarini P; Santoro L; Mussolin L; Carraro E; Pillon M; Bonaldi L; Vianello F; Agostinelli C; Ponzoni M; Dei Tos AP; Sabattini E
    Virchows Arch; 2024 Mar; 484(3):521-526. PubMed ID: 37962684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?
    Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
    Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pancreatic Collision Tumor Comprising Mantle Cell Lymphoma and Adenocarcinoma: A Case Report and Literature Review.
    Sugaya R; Taniguchi A; Abe M; Ozawa I; Kirito K; Hatakeyama S
    Intern Med; 2024 Feb; 63(4):553-558. PubMed ID: 37380453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulky primary tibia mantle cell lymphoma achieved complete remission with CHOP and DHAP plus rituximab: A case report.
    Chen S; Ye M
    Oncol Lett; 2018 Nov; 16(5):6116-6120. PubMed ID: 30344753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Involvement as a First Sign of CD5(-) Blastoid Mantle Cell Lymphoma.
    Zekey E; Öztürk Sarı Ş; Yeğen G; Darakcı S
    Balkan Med J; 2023 Oct; 40(6):456-459. PubMed ID: 37817481
    [No Abstract]   [Full Text] [Related]  

  • 10. Blastoid Mantle Cell Lymphoma Presenting as an Oropharyngeal Mass.
    Macapagal S; Wannaphut C; Takahashi T; Yinadsawaphan T; Nishimura Y; Acoba J
    Cureus; 2024 Mar; 16(3):e56378. PubMed ID: 38633973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5 negative mantle cell lymphoma: a different clinical entity?
    Alvarez-Argote J; Bauer FA; Dasanu CA
    Conn Med; 2014 Apr; 78(4):211-4. PubMed ID: 24830117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
    Tsuda K; Tanimoto T; Komatsu T
    N Engl J Med; 2016 Feb; 374(8):792-3. PubMed ID: 26933863
    [No Abstract]   [Full Text] [Related]  

  • 13. Mantle Cell Lymphoma.
    Cheah CY; Seymour JF; Wang ML
    J Clin Oncol; 2016 Apr; 34(11):1256-69. PubMed ID: 26755518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
    Dreyling M; Amador V; Callanan M; Jerkeman M; Le Gouill S; Pott C; Rule S; Zaja F;
    Leuk Lymphoma; 2015 Apr; 56(4):866-76. PubMed ID: 25015778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do mantle cell lymphomas have an 'Achilles heel'?
    Saba N; Wiestner A
    Curr Opin Hematol; 2014 Jul; 21(4):350-7. PubMed ID: 24857884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature.
    Hsu P; Yang T; Sheikh-Fayyaz S; Brody J; Bandovic J; Roy S; Laser J; Kolitz JE; Devoe C; Zhang X
    Int J Clin Exp Pathol; 2014; 7(3):1042-50. PubMed ID: 24696721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
    Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of aberrant CD5 expression in B-cell leukemia.
    Jaseb K; Purrahman D; Shahrabi S; Ghanavat M; Rezaeean H; Saki N
    Oncol Rev; 2019 Jan; 13(1):400. PubMed ID: 31044025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.